IDEAYA Biosciences (IDYA) EBIT (2018 - 2026)
IDEAYA Biosciences (IDYA) reported EBIT of -$108.5 million for Q1 2026, down 28.62% on a YoY basis from -$152.1 million in Q1 2025, and down 14.78% sequentially from -$94.6 million in Q4 2025.
IDEAYA Biosciences (IDYA) EBIT (2018 - 2026) Analysis & Trends
IDEAYA Biosciences (IDYA) has 9 years of EBIT data on file, last reported at -$108.5 million in Q1 2026.
- For the quarter ending Q1 2026, EBIT fell 28.62% year-over-year to -$108.5 million; the trailing twelve-month figure through Mar 2026 stood at -$183.5 million (up 49.09% YoY), and the FY2025 full-year result was -$159.3 million, up 51.28% from the prior year.
- EBIT retreated to -$108.5 million in Q1 2026, from -$94.6 million in the prior quarter.
- In the past five years, EBIT ranged from a high of $108.5 million in Q3 2025 to a low of -$144.1 million in Q4 2024.
- A 5-year average of -$46.6 million and a median of -$41.9 million in 2023 frame the typical range for EBIT.
- Across the five-year window, EBIT plunged 5179.7% in 2023 and surged 262.13% in 2025, its largest moves.
- Tracing IDYA's EBIT over 5 years: stood at -$26.4 million in 2022, then plunged by 58.52% to -$41.9 million in 2023, then tumbled by 243.87% to -$144.1 million in 2024, then surged by 34.39% to -$94.6 million in 2025, then declined by 14.78% to -$108.5 million in 2026.
- Business Quant data shows IDYA's EBIT at -$108.5 million in Q1 2026, -$94.6 million in Q4 2025, and $108.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | IDEAYA Biosciences | 3.21 Bn | 2.54 Bn | - | -108.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -108.54 Mn |
| Dec 31, 2025 | -94.57 Mn |
| Sep 30, 2025 | 108.45 Mn |
| Jun 30, 2025 | -88.81 Mn |
| Mar 31, 2025 | -84.39 Mn |
| Dec 31, 2024 | -144.14 Mn |
| Sep 30, 2024 | -66.89 Mn |
| Jun 30, 2024 | -64.93 Mn |
| Mar 31, 2024 | -51.02 Mn |
| Dec 31, 2023 | -41.92 Mn |
| Sep 30, 2023 | -33.53 Mn |
| Jun 30, 2023 | -32.71 Mn |
| Mar 31, 2023 | -26.28 Mn |
| Dec 31, 2022 | -26.44 Mn |
| Sep 30, 2022 | 660,000.00 |
| Jun 30, 2022 | -22.50 Mn |
| Mar 31, 2022 | -14.22 Mn |
| Dec 31, 2021 | -18.37 Mn |
| Sep 30, 2021 | -11.71 Mn |
| Jun 30, 2021 | -11.05 Mn |